nisoldipine has been researched along with Hypertrophy, Left Ventricular in 4 studies
Nisoldipine: A dihydropyridine calcium channel antagonist that acts as a potent arterial vasodilator and antihypertensive agent. It is also effective in patients with cardiac failure and angina.
nisoldipine : A racemate consisting of equimolar amounts of (R)- and (S)-nisoldipine. A calcium channel blocker, it is used in the treatment of hypertension and angina pectoris.
methyl 2-methylpropyl 2,6-dimethyl-4-(2-nitrophenyl)-1,4-dihydropyridine-3,5-dicarboxylate : A dihydropyridine that is 1,4-dihydropyridine which is substituted by methyl groups at positions 2 and 6, a methoxycarbonyl group at position 3, an o-nitrophenyl group at position 4, and an isobutoxycarbonyl group at position 5. The racemate, a calcium channel blocker, is used in the treatment of hypertension and angina pectoris.
Hypertrophy, Left Ventricular: Enlargement of the LEFT VENTRICLE of the heart. This increase in ventricular mass is attributed to sustained abnormal pressure or volume loads and is a contributor to cardiovascular morbidity and mortality.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Nisoldipine CC is an effective antihypertensive agent in both black and nonblack South African ethnic groups." | 2.40 | What does nisoldipine coat core (CC) add to current therapy that is clinically meaningful? ( Opie, LH, 1997) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (25.00) | 18.2507 |
| 2000's | 3 (75.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Havranek, EP | 1 |
| Esler, A | 1 |
| Estacio, RO | 1 |
| Mehler, PS | 1 |
| Schrier, RW | 1 |
| Opie, LH | 1 |
| Barth, W | 1 |
| Deten, A | 2 |
| Bauer, M | 1 |
| Reinohs, M | 1 |
| Leicht, M | 2 |
| Zimmer, HG | 2 |
| Briest, W | 1 |
| Hölzl, A | 1 |
| Rassler, B | 1 |
| Baba, HA | 1 |
1 review available for nisoldipine and Hypertrophy, Left Ventricular
| Article | Year |
|---|---|
What does nisoldipine coat core (CC) add to current therapy that is clinically meaningful?
Topics: Blood Pressure; Calcium Channel Blockers; Delayed-Action Preparations; Humans; Hypertension; Hypertr | 1997 |
1 trial available for nisoldipine and Hypertrophy, Left Ventricular
| Article | Year |
|---|---|
Differential effects of antihypertensive agents on electrocardiographic voltage: results from the Appropriate Blood Pressure Control in Diabetes (ABCD) trial.
Topics: Adult; Aged; Antihypertensive Agents; Blood Pressure; Calcium Channel Blockers; Diabetes Mellitus, T | 2003 |
2 other studies available for nisoldipine and Hypertrophy, Left Ventricular
| Article | Year |
|---|---|
Differential remodeling of the left and right heart after norepinephrine treatment in rats: studies on cytokines and collagen.
Topics: Adrenergic Antagonists; Animals; Atrial Natriuretic Factor; Calcium Channel Blockers; Carbazoles; Ca | 2000 |
Cardiac remodeling after long term norepinephrine treatment in rats.
Topics: Adrenergic Antagonists; Analysis of Variance; Animals; Blotting, Western; Calcium Channel Blockers; | 2001 |